Richard L. Schlenker
Analyst · Tim McHugh with William Blair
Thanks, Paul. We're pleased to have delivered another quarter of good financial results. Revenues before reimbursements, or net revenues as I will refer to them from here on, were $70.1 million, up 5.1% from $66.7 million in the same period of 2012. Total revenues for the quarter were $75.2 million, up 2.6% as compared to $73.3 million 1 year ago. Net income for the third quarter was $11.1 million or $0.79 per share as compared to $10.2 million or $0.72 per share 1 year ago. Our diluted share count decreased to 14 million from 14.2 million in the same period last year as a result of our ongoing repurchase program. EBITDA for the third quarter was $18.8 million, an increase of 8% over $17.4 million 1 year ago. EBITDA margin for the quarter was 26.8% of net revenue, which is an increase of 75 basis points over the same period in 2012. In our Defense Technology Development business, net revenues for the quarter were $2.9 million, which is down from $4.4 million in the third quarter of last year. Defense product sales were 0 in the third quarter and are expected to be the same in the fourth quarter. As a reminder, this will result in a $2 million lower net revenues from product sales as last year had $2 million and this year, again, we're expecting it to be 0. Utilization in the third quarter was 72% as compared to 74% in the third quarter of 2012, reflecting a step-down in a few major assignments and a decline in our defense business. Year-to-date, utilization is 73%. We expect 2013 full year utilization to be approximately 71%, and the fourth quarter to be in the mid-60s as a result of our seasonally low fourth quarter. In 2012, the step-down in utilization from the third quarter to the fourth quarter was 5 percentage points. Additionally, the extra week we are picking up this year includes the New Year's holiday, so we expect the utilization to further -- to be further impacted. For the third quarter of 2013, billable hours increased 2% over the same period last year to 273,000. We had a year-over-year FTE or full-time equivalent employee growth of 4.6% to 726. We also realized a year-over-year bill rate increase of approximately 2.5%. We expect headcount to grow another 1% sequentially in the fourth quarter. For the third quarter, compensation expense, after adjusting for gains, losses and deferred compensation, increased 3%. Included in total compensation expense is a gain in deferred compensation of $1.9 million as compared to $1.1 million in the same quarter of 2012. Gains and losses in deferred compensation are offset in miscellaneous income and have no impact on the bottom line. Stock-based compensation expense in the third quarter was $2.5 million. We expect stock-based compensation for the full year to be approximately $13 million. Other operating expenses in the third quarter increased to $6.4 million as compared to $5.9 million in the same period last year. Depreciation was $1.3 million and is included in other operating expenses. We expect operating expenses in the fourth quarter to be in the range of $6.5 million to $6.8 million. G&A expenses in the quarter were $3.7 million as compared to $3.5 million in the same quarter 1 year ago. We expect G&A expenses in the fourth quarter to be in the range of $4.2 million to $4.5 million. Our income tax rate in the quarter was 36.7% as we benefited from a one-time tax deduction. We expect the tax rate for the fourth quarter to be approximately 40.5%. Turning to the balance sheet. Operating cash flow was strong at $17.4 million. Our cash and short-term investments were $135 million at quarter end. Year-to-date, stock repurchases are $21.2 million or 389,000 shares. We still have 38 -- $34.8 million authorized and available for repurchases under our current repurchase program. We also distributed almost $6 million to shareholders through dividends year-to-date and today, announced our fourth quarter dividend. Capital expenditures in the third quarter were $890,000. DSOs were 94 days. In the third quarter, we continue to execute well and are excited about future opportunities for growth. Considering our better-than-expected performance year-to-date, we now expect growth in revenues before reimbursements for the full year to be in the middle single digits. We are also improving our 2013 outlook on EBITDA margin by 100 basis points to now be down by only 50 to 100 basis points as compared to the previous year. This guidance reflects reduced revenues from a few major assignments and a decline in defense business, which are offset by increased revenues from the rest of the business and the extra week in 2013. I will now turn the call back to Paul for closing remarks.